These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4886576)

  • 21. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.
    McKenzie JM; McCullagh EP
    J Clin Endocrinol Metab; 1968 Aug; 28(8):1177-82. PubMed ID: 4175472
    [No Abstract]   [Full Text] [Related]  

  • 22. New in vitro tests to detect the thyroid stimulator in sera from hyperthyroid patients by measuring colloid droplet formation and cyclic AMP in human thyroid slices.
    Onaya T; Kotani M; Yamada T; Ochi Y
    J Clin Endocrinol Metab; 1973 May; 36(5):859-66. PubMed ID: 4349046
    [No Abstract]   [Full Text] [Related]  

  • 23. Postpartum recurrence of hyperthyroidism and changes of thyroid-stimulating immunoglobulins in Graves' disease.
    Yabu Y; Amino N; Mori H; Miyai K; Tanizawa O; Takai SI; Kumahara Y; Matsuzuka F; Kuma K
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1454-8. PubMed ID: 6108332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
    Lamberg BA; Gordin A
    Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
    [No Abstract]   [Full Text] [Related]  

  • 25. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-acting thyroid stimulator (LATS) in toxic nodular goitre, toxic adenoma and Graves' disease.
    Lamberg BA; Gordin A; Viherkoski M; Kvist G
    Acta Endocrinol (Copenh); 1969 Oct; 62(2):199-209. PubMed ID: 5394703
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibody nature of the long-acting thyroid stimulator.
    Földes J; Takõ J; Bãnos C; Gesztesi E
    Acta Med Acad Sci Hung; 1971; 28(3):313-9. PubMed ID: 5154552
    [No Abstract]   [Full Text] [Related]  

  • 28. [Long-acting thyroid stimulator].
    Titov VN
    Klin Med (Mosk); 1969 Oct; 47(10):31-9. PubMed ID: 4915396
    [No Abstract]   [Full Text] [Related]  

  • 29. Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders.
    Mori T; Kriss JP
    J Clin Endocrinol Metab; 1971 Oct; 33(4):688-98. PubMed ID: 5109861
    [No Abstract]   [Full Text] [Related]  

  • 30. LATS protector, the human thyroid stimulator.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):22-3. PubMed ID: 1055310
    [No Abstract]   [Full Text] [Related]  

  • 31. Experimental production of a thyroid-stimulating antithyroid antibody.
    McKenzie JM
    J Clin Endocrinol Metab; 1968 May; 28(5):596-602. PubMed ID: 4172455
    [No Abstract]   [Full Text] [Related]  

  • 32. [Significance of the "long acting thyroid stimulator"].
    Tourneur R; Letonturier P; Sénécal P
    Cah Med; 1974 Mar; 15(3):121-3. PubMed ID: 4479615
    [No Abstract]   [Full Text] [Related]  

  • 33. Thyroid-stimulating activity in the serum of rabbits immunized with thyroid microsomes.
    Beall GN; Solomon DH
    J Clin Endocrinol Metab; 1968 Apr; 28(4):503-10. PubMed ID: 4868496
    [No Abstract]   [Full Text] [Related]  

  • 34. Pathogenesis of iodine-induced thyrotoxicosis: studies in northern Tasmania.
    Vidor GI; Stewart JC; Wall JR; Wangel A; Hetzel BS
    J Clin Endocrinol Metab; 1973 Dec; 37(6):901-9. PubMed ID: 4753432
    [No Abstract]   [Full Text] [Related]  

  • 35. Letter: L.A.T.S. and Graves' disease.
    Volpé R; Farid NR; Von Westarp C; Row VV
    Lancet; 1974 Oct; 2(7884):843. PubMed ID: 4138250
    [No Abstract]   [Full Text] [Related]  

  • 36. [LATS and thyroid antibody level in the blood in Basedow's disease].
    Földes J; Takó J; Bános C; Gesztesi E; Varga I
    Orv Hetil; 1968 Aug; 109(33):1799-804. PubMed ID: 5714825
    [No Abstract]   [Full Text] [Related]  

  • 37. The long-acting thyroid stimulator and the result of I 131 treatment for thyrotoxicosis.
    Martin FI; Larkins RG; Alford FP; Andrews JT; Greenberg PB; Melick RA; Penington JS
    Aust N Z J Med; 1972 May; 2(2):168-72. PubMed ID: 4116447
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunologic features of thyroid diseases.
    Beall GN; Solomon DH
    Postgrad Med; 1973 Nov; 54(5):181-9. PubMed ID: 4593774
    [No Abstract]   [Full Text] [Related]  

  • 39. Failure to produce experimental autoimmune thyrotoxicosis in rabbits immunized with thyroidal microsomes.
    Wall JR; Good BF; Hetzel BS
    Aust J Exp Biol Med Sci; 1973 Oct; 51(5):703-6. PubMed ID: 4787506
    [No Abstract]   [Full Text] [Related]  

  • 40. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].
    Busnardo B; Accordi F; Debiasi S
    Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.